Internal Medicine, Pulmonary Disease · Fresno, CA
NPI
1225146293
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
1243 E Spruce Ave Ste 104
Fresno, CA, 93720
Phone (559) 326-7659
Groups this clinician bills Medicare through
Medicare paid, 2024
$278K
5,508 services
Medicare patients, 2024
816
Average age 73
Drug cost, 2024
$2.2M
10,598 prescriptions
Company payments, 2025
$312
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chitra Kandaswamy was code 99214 (office e&m - established), 1,625 times for 659 patients. In total Chitra Kandaswamy billed 5,508 services in 17 codes, and Medicare paid $278K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,625 | 659 | $89.30 | $145K |
| 94010 Pulmonary Function Testing | Office | 1,446 | 715 | $19.92 | $29K |
| 94618 Pulmonary Function Testing | Office | 679 | 523 | $24.30 | $17K |
| 94060 Pulmonary Function Testing | Office | 409 | 402 | $28.58 | $12K |
| 94726 Pulmonary Function Testing | Office | 385 | 381 | $40.93 | $16K |
| 94729 Pulmonary Function Testing | Office | 385 | 381 | $42.16 | $16K |
| 99204 Office E&M - New | Office | 254 | 254 | $111.48 | $28K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 128 | 128 | $67.74 | $8,670 |
| 99213 Office E&M - Established | Office | 78 | 65 | $66.06 | $5,153 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 44 | $11.24 | $517 |
| 94016 Pulmonary Function Testing | Office | 42 | 42 | $16.16 | $679 |
| 99211 Office E&M - Established | Office | 20 | 20 | $17.71 | $354 |
By year: 2022 $300K for 5,154 services; 2023 $300K for 4,985 services; 2024 $278K for 5,508 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chitra Kandaswamy prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 2,848 prescriptions and refills. In total Chitra Kandaswamy wrote 10,598 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 2,848 | 3,370 | 1,028 | $84K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,146 | 1,241 | 340 | $748K |
| Montelukast Sodium Generic | 1,023 | 1,814 | 319 | $8,711 |
| Famotidine Generic | 1,016 | 1,557 | 291 | $8,953 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 606 | 646 | 193 | $280K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 511 | 671 | 186 | $275K |
| Spiriva Respimat Tiotropium Bromide | 307 | 384 | 136 | $165K |
| Ventolin Hfa Albuterol Sulfate | 275 | 321 | 112 | $15K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 235 | 415 | 125 | $148K |
| Breo Ellipta Fluticasone/Vilanterol | 224 | 238 | 54 | $92K |
| Azithromycin Generic | 216 | 219 | 168 | $1,020 |
| Levocetirizine Dihydrochloride Generic | 210 | 351 | 70 | $2,380 |
| Omeprazole Generic | 194 | 338 | 65 | $1,772 |
| Arnuity Ellipta Fluticasone Furoate | 169 | 201 | 60 | $51K |
| Mycophenolate Mofetil Generic | 167 | 222 | 46 | $7,661 |
Brand drugs: 5,620 claims; generic drugs: 4,978 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chitra Kandaswamy $312 ($312 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.